Pfizer Seeks FDA’s Approval for Younger Population’s Vaccination Aged 12 to 15 Year Olds Medicine & Technology Apr 09, 2021 Pfizer has asked the FDA for an amendment to its emergency use authorization for its COVID-19 vaccine to expand its use in individuals aged 12 to 15 in the United States.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts